Valeo Financial Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-624
| Closed | -$44K | – | 1833 |
|
|
2020
Q2 | $44K | Buy |
624
+10
| +2% | +$705 | ﹤0.01% | 741 |
|
|
2020
Q1 | $32K | Hold |
614
| – | – | ﹤0.01% | 723 |
|
|
2019
Q4 | $40K | Sell |
614
-27
| -4% | -$1.76K | ﹤0.01% | 716 |
|
|
2019
Q3 | $40K | Hold |
641
| – | – | ﹤0.01% | 666 |
|
|
2019
Q2 | $46K | Buy |
+641
| New | +$46K | 0.01% | 630 |
|
|
2019
Q1 | – | Sell |
-37
| Closed | -$3K | – | 1621 |
|
|
2018
Q4 | $3K | Sell |
37
-16
| -30% | -$1.3K | ﹤0.01% | 1202 |
|
|
2018
Q3 | $6K | Sell |
53
-2
| -4% | -$226 | ﹤0.01% | 1124 |
|
|
2018
Q2 | $8K | Hold |
55
| – | – | ﹤0.01% | 1008 |
|
|
2018
Q1 | $6K | Sell |
55
-3
| -5% | -$327 | ﹤0.01% | 1077 |
|
|
2017
Q4 | $5K | Buy |
+58
| New | +$5K | ﹤0.01% | 1006 |
|